Warning! GuruFocus detected
1 Medium warning sign
with SRDX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Surmodics Inc
NAICS : 325413
SIC : 3845
ISIN : US8688731004
Description
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.91 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | 14.72 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.71 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.8 | |||||
| 3-Year EBITDA Growth Rate | -31.7 | |||||
| 3-Year Book Growth Rate | -6.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.33 | |||||
| 9-Day RSI | 52.49 | |||||
| 14-Day RSI | 45.35 | |||||
| 3-1 Month Momentum % | -11.77 | |||||
| 6-1 Month Momentum % | -10.51 | |||||
| 12-1 Month Momentum % | 26.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.45 | |||||
| Quick Ratio | 4.29 | |||||
| Cash Ratio | 2.29 | |||||
| Days Inventory | 78.6 | |||||
| Days Sales Outstanding | 37.52 | |||||
| Days Payable | 14.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | -0.24 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.97 | |||||
| Operating Margin % | -6.22 | |||||
| Net Margin % | -11.48 | |||||
| FCF Margin % | -1.54 | |||||
| ROE % | -12.11 | |||||
| ROA % | -8.16 | |||||
| ROIC % | -8.65 | |||||
| 3-Year ROIIC % | 77.48 | |||||
| ROC (Joel Greenblatt) % | -14.5 | |||||
| ROCE % | -3.91 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.43 | |||||
| PB Ratio | 3.87 | |||||
| Price-to-Tangible-Book | 9.02 | |||||
| Price-to-Operating-Cash-Flow | 365.07 | |||||
| EV-to-EBIT | -70.58 | |||||
| EV-to-EBITDA | 195.02 | |||||
| EV-to-Revenue | 3.49 | |||||
| EV-to-Forward-Revenue | 3.24 | |||||
| EV-to-FCF | -227.06 | |||||
| Price-to-GF-Value | 0.81 | |||||
| Price-to-Projected-FCF | 5.15 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 21.8 | |||||
| Earnings Yield (Greenblatt) % | -1.42 | |||||
| FCF Yield % | -0.45 | |||||
| Forward Rate of Return (Yacktman) % | -15.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SRDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Surmodics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 125.448 | ||
| EPS (TTM) ($) | -1.01 | ||
| Beta | 1.5 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 70.2 | ||
| 14-Day RSI | 45.35 | ||
| 14-Day ATR ($) | 1.254539 | ||
| 20-Day SMA ($) | 30.3495 | ||
| 12-1 Month Momentum % | 26.57 | ||
| 52-Week Range ($) | 25.17 - 42.44 | ||
| Shares Outstanding (Mil) | 14.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surmodics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Surmodics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Surmodics Inc Frequently Asked Questions
What is Surmodics Inc(SRDX)'s stock price today?
The current price of SRDX is $30.30. The 52 week high of SRDX is $42.44 and 52 week low is $25.17.
When is next earnings date of Surmodics Inc(SRDX)?
The next earnings date of Surmodics Inc(SRDX) is 2025-05-01 Est..
Does Surmodics Inc(SRDX) pay dividends? If so, how much?
Surmodics Inc(SRDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers